Growth Metrics

Lipocine (LPCN) FCF Margin (2018 - 2025)

Historic FCF Margin for Lipocine (LPCN) over the last 8 years, with Q3 2025 value amounting to 2605.93%.

  • Lipocine's FCF Margin changed N/A to 2605.93% in Q3 2025 from the same period last year, while for Sep 2025 it was 119.12%, marking a year-over-year decrease of 529800.0%. This contributed to the annual value of 11.71% for FY2024, which is 4049800.0% up from last year.
  • Lipocine's FCF Margin amounted to 2605.93% in Q3 2025.
  • Lipocine's 5-year FCF Margin high stood at 5888.93% for Q1 2021, and its period low was 12692.34% during Q3 2021.
  • Its 5-year average for FCF Margin is 1643.74%, with a median of 302.84% in 2025.
  • Per our database at Business Quant, Lipocine's FCF Margin skyrocketed by 71821000bps in 2024 and then tumbled by -21296000bps in 2025.
  • Quarter analysis of 5 years shows Lipocine's FCF Margin stood at 55.92% in 2021, then tumbled by -1193bps to 611.33% in 2022, then surged by 254bps to 939.68% in 2023, then crashed by -95bps to 48.46% in 2024, then plummeted by -5478bps to 2605.93% in 2025.
  • Its FCF Margin was 2605.93% in Q3 2025, compared to 302.84% in Q2 2025 and 2097.99% in Q1 2025.